Lupin secures FDA approval for generic Emtricitabine and Tenofovir Alafenamide tablets EP News Bureau Dec 18, 2024 Lupin to launch generic version of Descovy with 180-day exclusivity, targeting HIV treatment market
Lupin secures tentative U.S. FDA approval for generic HIV treatment under PEPFAR EP News Bureau Jul 31, 2024 Lupin to manufacture and supply affordable Emtricitabine and Tenofovir Alafenamide tablets from Nagpur facility to low and…
Strides Arcolab, Gilead Sciences agreement Usha Sharma Jan 20, 2015 To manufacture and distribute Tenofovir Alafenamide (TAF) based HIV treatments in 112 developing countries
